Mumbai: The Sparsh Group of Hospitals, a Bengaluru-based regional hospital chain promoted by orthopaedic surgeon Sharan Shivaraj Patil, will make investments in new hospitals and an R&D centre, and is considering raising funds through equity.
The hospital chain will look at an initial public offering or a sale of shares to private equity firms among other options once it completes the investments in new hospitals and R&D, Patil said in an interview to ET. “We would like to start the process for fundraising in the last quarter (January-March) of fiscal 2026.”
In an industry flush with PE money, Sparsh is among a few doctor-driven regional chains that have stayed out.
“PEs will definitely help (us) to grow much faster and do things at scale, but I didn’t want to be rushed, wanting my independence,” Patil said. The company is profitable and debt free, “but we will add some debt for the ongoing expansion”, Patil said.
Sparsh will be spending around ₹350-400 crore to set up two new hospitals in North and East of Bengaluru with a combined capacity of 550 beds. These will be ready for commercial operations in four to six months, Patil said.
It will also be spending up to ₹150 crore to set up an R&D centre, to drive innovation and improvements in processes and systems. It has launched India’s first advanced on-site 3D printing lab for customised implants and prosthetics.
“We are also working on making joint-replacement surgeries day care, from the current turnaround of 2.0-2.5 days,” he said.
